Introduction: Based on old studies, Streptozocin (STZ) is known to have some renal toxicity.
Aim(s): We investigated the renal effects of STZ with current dosing regimens and renal surveillance in a 2-part study (retrospective and prospective part).
Materials and methods: Patients with GEP-NETS treated with STZ were included. The primary endpoint was the percentage of patients who had a decrease of estimated Glomerular Filtration Rate (eGFR) of at least 25% (MDRD formula) compared to baseline. We report here the results of the retrospective part of the study.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Medical treatment - Chemotherapy
Presenting Author: Emmanuel Mitry
, Brixi H
, Lecomte T
, Lombard-Bohas C
, Seitz J F
, Legoux J L
, Mahamat A
, Ruszniewski P
, Etienne P L
, Le Malicot K
, Lepage C
, Choukroun G
To read results and conclusion, please login ...
Further abstracts you may be interested in